BIOMAT Database Logo BIOMAT Database Logo

[Clinical effects of dipyridamole (Persantin) on nephrotic syndrome--multiclinic double blind test (author's transl)]. 1979

Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009404 Nephrotic Syndrome A condition characterized by severe PROTEINURIA, greater than 3.5 g/day in an average adult. The substantial loss of protein in the urine results in complications such as HYPOPROTEINEMIA; generalized EDEMA; HYPERTENSION; and HYPERLIPIDEMIAS. Diseases associated with nephrotic syndrome generally cause chronic kidney dysfunction. Childhood Idiopathic Nephrotic Syndrome,Frequently Relapsing Nephrotic Syndrome,Multi-Drug Resistant Nephrotic Syndrome,Pediatric Idiopathic Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndrome,Steroid-Resistant Nephrotic Syndrome,Steroid-Sensitive Nephrotic Syndrome,Multi Drug Resistant Nephrotic Syndrome,Nephrotic Syndrome, Steroid-Dependent,Nephrotic Syndrome, Steroid-Resistant,Nephrotic Syndrome, Steroid-Sensitive,Nephrotic Syndromes,Steroid Dependent Nephrotic Syndrome,Steroid Resistant Nephrotic Syndrome,Steroid Sensitive Nephrotic Syndrome,Steroid-Dependent Nephrotic Syndromes,Steroid-Resistant Nephrotic Syndromes,Steroid-Sensitive Nephrotic Syndromes,Syndrome, Nephrotic,Syndrome, Steroid-Sensitive Nephrotic
D011507 Proteinuria The presence of proteins in the urine, an indicator of KIDNEY DISEASES. Proteinurias
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004176 Dipyridamole A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752) Antistenocardin,Apo-Dipyridamole,Cerebrovase,Cléridium,Curantil,Curantyl,Dipyramidole,Kurantil,Miosen,Novo-Dipiradol,Persantin,Persantine,Apo Dipyridamole,Novo Dipiradol
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Dipyridamole therapy in the nephrotic syndrome (author's transl)].
March 1978, Nihon Jinzo Gakkai shi,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[The therapeutical effect of dipyridamole on chronic glomerulonephritis and nephrotic syndrome in large dose administration--the study in a double blind group comparison method (author's transl)].
February 1979, Nihon Jinzo Gakkai shi,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Double-blind clinical study of rohypnol (author's transl)].
August 1975, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
PERSANTIN-- A DOUBLE BLIND STUDY.
June 1964, Angiology,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Antidepressant action of amineptine: controlled double blind test (author's transl)].
January 1979, Therapie,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Complication during the dipyridamole-test (author's transl)].
April 1979, Medizinische Klinik,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Double-blind clinical study of carpipramine/placebo (author's transl)].
January 1976, Arzneimittel-Forschung,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
[Paraneoplastic nephrotic syndrome (author's transl)].
March 1974, Deutsche medizinische Wochenschrift (1946),
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
Evaluation of dipyridamole (Persantin).
March 1963, American heart journal,
Y Ueda, and S Tojo, and M Hatano, and T Furukawa, and K Yoshinaga, and Y Kinoshita, and J Takeuchi, and E Kato, and J Ohno, and K Kobayashi, and H Abe, and S Omae
Effects of Dose Titration on Dipyridamole-Induced Headache: A Randomized, Double-Blind Clinical Trial.
January 2022, Cerebrovascular diseases (Basel, Switzerland),
Copied contents to your clipboard!